Brief: Amneal Pharma Expects To Meet Or Exceed Its 2025 Full-Year Financial Guidance
13/01/2026 12:48
Jan 13 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O: AMNEAL PHARMA: EXPECTS TO MEET OR EXCEED ITS 2025 FULL-YEAR FINANCIAL GUIDANCE FY2025 EARNINGS PER SHARE VIEW $0.80, REVENUE VIEW $3.01 BILLION -- LSEG IBES DATA Further company coverage: AMRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsFocus: US progesterone supplies tighten as menopause treatment demand grows
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
Amneal Pharma up after Parkinson’s drug shows benefit in late-stage study